drugset / Trial / NCT06525649
A Double Blind, Randomized, Cross-over Study Examining the Suppression of the Photoparoxysmal EEG Response With NPT 2042
RandomizedCrossoverQuadruple-blindOther
Summary
A double-blind, placebo-controlled, crossover trial to investigate the PPR of approximately 5 subjects with a known stable PPR on EEG, using 2 doses of NPT 2042 compared to placebo.
Timeline
- Start
- 2024-08-21
- Primary completion
- 2025-06-26
- Completion
- 2025-06-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | NPT 2042 | Unknown | 160 mg | — |
| Comparator | NPT 2042 | Unknown | 240 mg | — |